Debjit Chattopadhyay Initiated (SRPT) at Strong Buy and Held Target at $75 on, Dec 1st, 2017
Debjit has made no other calls on SRPT in the last 4 months.
There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 1 agrees with Debjit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gena Wang of "Barclays" Maintained at Hold with Increased Target to $49 on, Thursday, October 26th, 2017
These are the ratings of the 2 analyists that currently disagree with Debjit
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy on, Monday, October 2nd, 2017
- Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $81 on, Thursday, September 7th, 2017
on: Thu, Dec 22nd 2016
by: WOPRAI
Anupam Rama Initiated (SRPT) at Buy and Held Target at $40 on, Dec 22nd, 2016
on: Thu, Nov 09th 2017
by: WOPRAI
David Lebovitz Maintained (ALNY) at Hold with Increased Target to $130 on, Nov 9th, 2017
on: Mon, Oct 30th 2017
by: WOPRAI
Matthew Luchini Maintained (BLUE) at Buy with Increased Target to $162 on, Oct 30th, 2017
on: Thu, Oct 27th 2016
by: WOPRAI
Matthew Harrison Initiated (SRPT) at Hold on, Oct 27th, 2016
on: Thu, Nov 09th 2017
by: WOPRAI
on: Wed, Nov 08th 2017
by: WOPRAI
Madhu Kumar Maintained (ALNY) at Strong Buy with Decreased Target to $220 on, Nov 8th, 2017
on: Wed, Nov 08th 2017
by: WOPRAI
Geoff Meacham Maintained (ALNY) at Buy with Increased Target to $158 on, Nov 8th, 2017
on: Fri, Nov 03rd 2017
by: WOPRAI
Alethia Young Maintained (ALNY) at Buy with Increased Target to $151 on, Nov 3rd, 2017
on: Thu, Nov 02nd 2017
by: WOPRAI
Rahul Jasuja Maintained (ALNY) at Strong Buy with Increased Target to $240 on, Nov 2nd, 2017
on: Mon, Oct 30th 2017
by: WOPRAI
Rahul Jasuja Initiated (ALNY) at Strong Buy and Held Target at $150 on, Oct 30th, 2017
on: Thu, Oct 26th 2017
by: WOPRAI
Gena Wang Maintained (SRPT) at Hold with Increased Target to $49 on, Oct 26th, 2017
on: Thu, Oct 26th 2017
by: WOPRAI
Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $193 on, Oct 26th, 2017
